ACS Study Recommends Increased Screening to Reduce Incidence of Colorectal Cancer
The study, published in the journal Cancer
found that increasing screening rates to 80% by 2018 would reduce projected colorectal cancer incidence rates by 17% and mortality rates by 19% during short-term follow-up, and by 22% and 33%, respectively, during extended follow-up. Those reductions would amount to a total of 277,000 averted new cancers and 203,000 averted colorectal cancer deaths from 2013 through 2030.
Secretary Burwell Reflects on Open Enrollment and Looks Ahead
Although HHS Secretary Sylvia M. Burwell touted the success of this past open enrollment period and the affordability of quality health plans, she declined to comment on King v. Burwell
during her keynote speech at America’s Health Insurance Plans (AHIP)’s National Health Policy Conference.
Dietary Restrictions Could Prevent Colon Cancer
The study, published in JAMA Internal Medicine
, found that while the complete absence of meat in the diet had the most impact on reducing the risk of colorectal cancer, those who added seafood to the vegetarian diet—pescovegetarians—faired better than the nonvegetarians.
Study Shows Experienced Care Facilities Improve Survival in NSCLC
The study, published in the Journal of Thoracic Oncology
, found that patients treated with definitive concurrent chemotherapy and radiation therapy for stage 3 non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, either academic or community cancer centers.
Medicaid Expansion Not Happening in Montana
Obamacare’s tenuous toehold in Montana appears to be growing no firmer. Despite a hearing crowded with supporters of the Democratic governor’s Medicaid expansion bill, Republican legislators have dealt the measure a likely death blow.
NICE Recommends Gazyvaro for Treatment-Naive CLL Patients
The recommendation has not come easy for Roche. Back in October 2014, NICE had rejected Gazyravo based on inconsistencies in the filing, which were then addressed by the drug manufacturer. Subsequently, NICE struck a deal with Roche to provide the drug to NHS at a reduced price.
ACA Causes Modest Change in ED Use Among Young Adults
Young adults appear to have changed their use of the emergency department since the implementation of the Affordable Care Act to reflect a more efficient use of medical care, according to a new report in the Annals of Emergency Medicine
Amgen Plans for Up to 5 Biosimilars by 2019
At a state-of-the-art facility in Thousand Oaks, California, drugmaker Amgen Inc. is perfecting the art of copying others, and it must work fast because copycats are already coming for Amgen's drugs.
Escalating Drug Prices Not a Concern for All
While the PBM Express Scripts declared plans to bring cancer drug plans down, the drug manufacturers and investors aren't too worried about the high cost of some of the specialty drugs, according to this article in Bloomberg